NewsWhore
01-07-2011, 01:00 PM
LONDON ? AstraZeneca PLC said the U.S. Food and Drug Administration will take three more months to review the British company's application for vandetanib, a drug it is developing as a treatmen
More... (http://story.argentinastar.com/index.php/ct/9/cid/d9ed072d737073b4/id/41833692/)
More... (http://story.argentinastar.com/index.php/ct/9/cid/d9ed072d737073b4/id/41833692/)